-
Product Insights
NewPTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Product Insights
Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NA-901 in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NA-901 in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NA-901 in Major Depressive Disorder Drug Details: NA-901 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NA-921 in Fragile X Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NA-921 in Fragile X Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NA-921 in Fragile X Syndrome Drug Details: NA-921 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NA-921 in Rett Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NA-921 in Rett Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NA-921 in Rett Syndrome Drug Details: NA-921 is under development for the...
-
Product Insights
NewPTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTA Peripheral DCB Catheters Pipeline Market Report Overview A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Melatonin in Chemotherapy Induced Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Melatonin in Chemotherapy Induced Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Melatonin in Chemotherapy Induced Oral Mucositis Drug Details: Melatonin (SP-13004)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Elixcyte in Chronic Kidney Disease (Chronic Renal Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Elixcyte in Chronic Kidney Disease (Chronic Renal Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Elixcyte in Chronic Kidney Disease (Chronic Renal Failure)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NA-931 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NA-931 in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NA-931 in Obesity Drug Details: NA-931 is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cell Therapy For Non-Small Cell Lung Cancer in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cell Therapy For Non-Small Cell Lung Cancer in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cell Therapy For Non-Small...